Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Both are paid to be 'bullish'
Funny seeing these posts as you trimmed just as it looked to break out under huge volume. This has now broken out of Stage 1 and since then, all it's done is re-test that pivot and ready for another move up. Massive gap above too to fill to 9p as Archy rightly says.
This pullback is on low volume so I think we move up next week. A hold of the 8ema today would be nice and confirm that.
Just curious and mean no offense, but on what planet do you see a company whose share price is 4.25p being bought for £1.80?
There is no gap to 50p troll lol
It makes me laugh when people spend all this time and energy talking down a stock they're not invested in. Get a life. What's more likely is there's a hidden agenda. One update from Richard or a first sale and this rockets. Considering they have sold a few of these already, its usage in the marketplace has already been established.
Considering you can sell 100k above the ask in one hit suggests this is a tree shake.
Can you repost?
Undoubtedly will be much higher - certainly in the high 5 figures I would have thought at least.
But I agree with other comments that they won't be allowed to become a FTSE 100 company in their own right because the commercial power and contacts of Bracco will make a takeover attempt at a large premium very attractive.
Bracco will likely take them out before then. They're not shareholders here just for the equity.
I expected about this price action. The next RNS will be FDA confirmation. Expect it then to be in the 70s as the countdown begins. If the FDA were to somehow categorise this as a Class 1 resubmission, then it flies even higher. I like that Polarean issued the conservative 6 months guidance in the RNS.
The Xenon does satisfy the requirements. What the FDA wanted assurance on was that the new manufacturer would polarise the Xenon to those same specs.
sajy, I believe the main points were around manufacturing as POLX had a new manufacturer and the FDA wanted guarantee that they would polarise the Xenon to the exact same specs as their previous manufacturer did.
If the below response is genuine, then it is completely disingenuous for the CEO to not understand why the share price has dipped this much with this type of volume.
True. Let's see how it plays out towards the end of the year when 1.9m are due to be exercised. Perhaps it's anticipation of that causing the downward pressure?
Pulling a fast one - meaning while he's in interviews pretending he doesn't understand why SP is dropping, he may well be cashing in his 30p and 40p warrants while the SP tanks. It's a possibility.
Simple profit taking for months on end for a company with supposedly killer fundamentals, big growth pipeline, in one of the hottest sectors doesn't add up I'm afraid.
Supply chain issues have been largely priced in to most equities. This is now over a 50% drop and supply chain issues doesn't explain it. I imagine this will continue dropping until those warrants expire end of Dec or earth shattering news comes in. I think the CEO is pulling a fast one here on PIs. 72p likely to be some support or 68p above the volume shelf, but judging how 90p was sliced through, we'll have to wait and see.
Maybe it's falling because of the, just under, 2m warrants due to expire in Dec 2021, held by the family. With the amount of ordinary shares they hold, it's highly likely they've been cashing these in while telling the world they are mystified why the SP is falling.